清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Mechanical thrombectomy in in-stent restenosis: preliminary experience at the iliac and femoropopliteal arteries with the Rotarex System.

医学 外科 腹股沟 再狭窄 经皮 截肢 髂外动脉 栓塞 血管成形术 支架 放射科
作者
Roberto Silingardi,Valentina Cataldi,Roberto Moratto,Ilaria Azzoni,Jessica Veronesi,Gilberto Coppi
出处
期刊:PubMed [National Institutes of Health]
卷期号:51 (4): 543-50 被引量:29
链接
标识
摘要

Iliac and femoropopliteal arterial stenting remains controversial due to frequent restenosis. This study aims to evaluate the efficacy of a mechanical rotational thrombectomy procedure with the Rotarex Mechanical Thrombectomy System (Straub Medical, Wangs, CH) and percutaneous transluminal angioplasty (PTA) in terms of technical success, patency rates and limb salvage.From May 2006 to March 2010, 32 selected patients with sub-acute or chronic in-stent restenosis at the iliac or femoropopliteal arteries were treated with a Rotarex and then PTA procedure.Technical success was 100%. Intra-procedural complications included a superficial femoral artery (SFA) dissection (1), SFA (1) and external iliac (1) perforations and a groin hematoma (1). There was no incidence of embolization in this series. One patient required reintervention (3.1%); an attempted surgical bypass and amputation. Secondary reinterventions were required in 17 patients (53.1%). Limb salvage rate at 12 months was 90.6%. Primary patency at 30 days was 96.8%. Primary, primary assisted and secondary patency rates at 6 months were 75%, 75% and 89.6% and at 12 months were 58.1%, 58.1% and 75.5%, respectively. Late mortality was 18.75% at an average follow-up of 13.1 months (3-45) due to the severe disease state of these patients..This treatment seems promising in terms of technical success and embolization risk. Reinterventions are frequently required but mid-term limb salvage rates are encouraging. Larger, randomised studies are needed to determine the cost/benefit advantage and long-term results.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助落寞涑采纳,获得50
2秒前
隐形的灵薇完成签到,获得积分10
11秒前
仁爱的鞋子完成签到,获得积分10
37秒前
心灵美的又琴完成签到,获得积分10
1分钟前
djfndnn完成签到 ,获得积分10
1分钟前
贤惠的觅夏完成签到,获得积分10
1分钟前
lumi应助科研通管家采纳,获得10
1分钟前
lumi应助科研通管家采纳,获得10
1分钟前
lumi应助科研通管家采纳,获得10
1分钟前
lumi应助科研通管家采纳,获得10
1分钟前
GXY完成签到,获得积分10
1分钟前
顾矜应助研友_惊鸿采纳,获得30
2分钟前
年123完成签到 ,获得积分10
2分钟前
2分钟前
研友_惊鸿发布了新的文献求助30
2分钟前
烂漫梦岚完成签到,获得积分10
2分钟前
冷傲的莫言完成签到,获得积分10
2分钟前
吉吉完成签到 ,获得积分10
2分钟前
张啦啦完成签到 ,获得积分10
2分钟前
高大星月完成签到,获得积分10
3分钟前
OK关闭了OK文献求助
3分钟前
漂亮孤风完成签到,获得积分10
3分钟前
kk完成签到 ,获得积分10
3分钟前
lucky完成签到 ,获得积分10
4分钟前
李木禾完成签到 ,获得积分10
4分钟前
忧郁小鸽子完成签到,获得积分10
4分钟前
aspect完成签到 ,获得积分10
4分钟前
笑点低的如萱完成签到,获得积分10
4分钟前
drkyy完成签到,获得积分10
5分钟前
快乐碱基对完成签到 ,获得积分10
5分钟前
艳艳宝完成签到 ,获得积分10
5分钟前
lx完成签到 ,获得积分10
5分钟前
5分钟前
谦让的忆枫完成签到,获得积分10
5分钟前
智者雨人完成签到 ,获得积分10
6分钟前
阿巴完成签到,获得积分10
6分钟前
耍酷的冷雪完成签到,获得积分10
6分钟前
默默然完成签到 ,获得积分10
6分钟前
阳光的丹雪完成签到,获得积分10
6分钟前
共享精神应助阳光的丹雪采纳,获得10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
Management and the Arts 310
Teaching Social and Emotional Learning in Physical Education 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7634137
求助须知:如何正确求助?哪些是违规求助? 9208183
关于积分的说明 19748268
捐赠科研通 7202444
什么是DOI,文献DOI怎么找? 3275028
关于科研通互助平台的介绍 2436932
邀请新用户注册赠送积分活动 2271930